Human T-cell lymphotropic virus types 1 and 2 antibodies seroprevalence among blood donors at national public health blood bank, Khartoum- Sudan 2019

Goris BMT

Pdf Page Numbers :- 100-104

Babbiker Mohammed Taher Goris^1,*

¹Department of Medical Microbiology, Faculty of Medical Laboratory Sciences, Sudan University of Science and technology, Sudan

*Corresponding author: Babbiker Mohammed Taher Gorish, Ph.D. in Medical Microbiology, Department of Microbiology and Immunology - Faculty of Medical Laboratory Science, Omdurman Islamic University, Sudan. Email: qorish456@gmail.com

Received 24 March 2019; Revised 27 May 2020; Accepted 10 June 2020; Published 18 June 2020

Citation: Goris BMT. Human T-cell lymphotropic virus types 1 and 2 antibodies seroprevalence among blood donors at national public health blood bank, Khartoum- Sudan 2019. J Med Sci Res. 2020; 8(3):100-104. DOI: http://dx.doi.org/10.17727/JMSR.2020/8-14

Copyright: © 2020 Goris BMT. Published by KIMS Foundation and Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PDF

Abstract

The human T-cell lymphotropic virus types 1 and 2 (HTLV 1/2) are well known causes of adult T cell leukemia lymphoma. Both viruses were established to be transmitted through various mode including sexual contact and blood transfusion. This study was aimed to determine the seroprevalence of HTLV-1/2 antibodies among blood donors in Public Health Laboratory. During the period of August 2019 to October 2019 a total of 394 blood samples were obtained from blood donors visiting the Blood bank of National Public Health Laboratory, both males and females were included. The blood samples were analyzed for the presence of anti - HTLV-1,2 by a commercially available enzyme-linked immune-sorbent assay following the instructions of the manufacturer. The study participants were included 361 (91.6%) males and 33 (8.4%) females. The result show that of the 394 blood donors, four (4) were found to be seropositive for HTLV-1 antibodies giving a prevalence of 1.02%. While all samples were negative for the HTLV-2 antibodies. Among HTLV-1 positive cases 3 were male (75%) while only one female (25%) was found to be seropositive for HTLV-1 antibodies. None of the married donors was found to be seropositive for HTLV-1. We conclude that the seroprevalence of HTLV 1/2 were matched to the internationally estimated prevalence among blood donors at Blood Bank of national health laboratory and the majority of the cases were male under 40 years old. Further studies should be done with inclusion of more samples and using more sensitive technique like Western blot or PCR.

Keywords: HTLV1/2; blood bank; seroprevalence; ELISA kit